A Biosimilars Update
Tuesday, November 5, 2019
7 p.m. ET | 6 p.m. CT | 5 p.m. MT | 4 p.m. PT | Time zone converter
If you're wondering about the status of biosimilars since the first biosimilar Inflectra was approved by the FDA in 2016, then this webinar is for you! Hear Dr. Paul Yamauchi, dermatologist at Dermatology Institute and Skin Care Center, Clinical Science Institute in Santa Monica, Ca. and key opinion leader in the field of psoriasis, present the differences between a biologic and a biosimilar, current and upcoming biosimilars, and implications as a treatment option.
Have a schedule conflict? Unable to make it? Register anyway and you will receive the webinar recording link to watch at a time convenient for you. Share this link with a friend or family member who may have an interest in this topic.
Contact Bev Bromfield, Outreach Manager, at [email protected] or 800-723-9166, ext. 362.
The views and opinions expressed in the webcasts are those of the speakers. The speakers' views and opinions are not endorsed by the National Psoriasis Foundation or its sponsors.